Physician

Robert Ray Reynolds, M.D.

According to 2025 Medicare claims, Robert Reynolds, M.D. (NPI: 1285868968) practices radiation oncology in the Bismarck, ND market, with the plurality of this provider's patient population coming from Burleigh, ND. This provider's primary affiliated billing organization is BISMARCK CANCER CENTER (NPI: 1538212162; TIN: 450454363) and primary practice location at 58501-4445. Reynolds is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Reynolds' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 414 traditional Medicare patients, billed 7,674 HCPCS/CPT codes, and received $1,508,850 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 234 prescription claims across 99 beneficiaries totaling $3,133 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2017 DME data shows 45 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $239,127 to $1,508,850. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $9,746 to $3,133. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	215	3,324	$239,127
2016	304	4,316	$305,914
2017	357	4,288	$296,070
2018	505	6,522	$1,060,434
2019	414	9,350	$1,735,521
2020	357	7,431	$1,430,345
2021	370	7,053	$1,383,799
2022	357	6,557	$1,226,254
2023	390	7,176	$1,404,633
2024	414	7,674	$1,508,850

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	87	247	$9,746
2016	119	587	$17,434
2017	117	494	$11,790
2018	117	345	$7,829
2019	94	260	$5,445
2020	75	196	$3,353
2021	74	234	$4,511
2022	87	223	$4,204
2023	99	274	$5,505
2024	99	234	$3,133

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,983
2016	N/R	36	$3,314
2017	N/R	45	$4,801
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	135	1,895	$300
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	192	$102
77014	Ct guidance for insertion of radiation therapy fields	144	1,957	$100
77336	Continuing radiation therapy consultation per week	143	522	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	131	155	$69

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	92	5,922	$1,650
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	128	$271
Dexamethasone	Dexamethasone	17	672	$251
Levofloxacin	Levofloxacin	26	75	$39
Lorazepam	Lorazepam	24	62	$29

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Robert Ray Reynolds, M.D.?

Tedicare shows public-source Medicare data for Robert Ray Reynolds, M.D. (NPI 1285868968), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Ray Reynolds, M.D. have ACO affiliation data?

Robert Ray Reynolds, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Robert Ray Reynolds, M.D.?

Robert Ray Reynolds, M.D. is linked to BISMARCK CANCER CENTER (billing NPI 1538212162) in the available physician profile data.

Does Robert Ray Reynolds, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.